Ontology highlight
ABSTRACT: Background
Identification of non-human leukocyte antigen (HLA) genetic risk factors could improve survival after allogeneic blood or marrow transplant (BMT) through matching at additional loci or individualizing risk prediction. We hypothesized that non-HLA loci contributed significantly to 1-year overall survival (OS), disease related mortality (DRM) or transplant related mortality (TRM) after unrelated donor (URD)BMT.Methods
We performed a genome-wide association study (GWAS) in 2,887 acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and acute lymphoblastic leukemia (ALL) patients and their ≥8/8 HLA-matched URDs comprising two independent cohorts treated from 2000-2011.Findings
Using meta-analyses of both cohorts, genome-wide significant associations (<
SUBMITTER: Hahn T
PROVIDER: S-EPMC8548922 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature